About
R&D
Approach
Therapeutic areas
Scientific publications
R&D centers
Scientific and medical board
Scientific partnerships
Pipeline
Overview
TOTUM•63
TOTUM•070
TOTUM•854
TOTUM•448
Manufacturing
Investors
Presentation
Shareholder space
Financial Information
Breakdown of Share Capital
Financial Calendar
Regulatory information
Annual general meeting
Newsroom
News
Releases
Media resources
FR
EN
SQLNM congress
Home
>
SQLNM congress
22nd scientific meeting of SQLNM
On the occasion of the 22nd scientific meeting of SQLNM, CMDO and COLosSUS, in Canada, Valbiotis presents the positive preclinical data obtained with TOTUM•070 against hypercholesterolemia.
